MT needs to go. If anything, you cannot afford him. His price is way above what is acceptable for a loss-making venture on its last legs.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025